![china-med-device-logo-rev_c80e4f9e9f2d285c4b08ea5c15ae79c4[1]](https://chinameddevice.com/wp-content/uploads/2018/09/china-med-device-logo-rev_c80e4f9e9f2d285c4b08ea5c15ae79c41.png){kind=logo}
May 22, 2019
NMPA issued “Notice on the Application of Certificate Authority (CA) certificate for Medical Device Registration Service Platform (eRPS)” on May 7, which introduced the Certificate Authority (CA) to all the […]
May 17, 2019
NMPA published draft version of IVD Clinical Trial Guideline for feedback on November 22, 2018. The draft guideline lists eight requirements for IVD clinical protocol. General information Including product information, […]
May 14, 2019
Varian announced on May 9 that it has signed a cooperation agreement with Shandong Cancer Hospital in China, on proton therapy clinical application and research. Varian has selected Shandong Cancer […]
May 10, 2019
Primarily due to the pressing problem of doctor shortage, the Chinese government is eagerly encouraging medical use of Artificial Intelligence. Currently, China has two kinds of license for AI medical […]
May 7, 2019
Monthly NMPA (CFDA) News Roundup covers government announcement, policies, standards, guidelines, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by ChinaMed Device, LLC (www.ChinaMedDevice.com), […]